Autologous transplant for relapsed follicular lymphoma: impact of pre-transplant rituximab sensitivity

Rituximab-refractory follicular lymphoma (FL) patients have limited options. Before the rituximab era, autologous stem cell transplantation (ASCT) was shown to improve outcomes in chemotherapy-sensitive, relapsed FL, but the impact of rituximab-sensitivity on these results is unknown. We analyzed 19...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Leuk Lymphoma
Main Authors: Phipps, Colin, Gopal, Ajay K., Storer, Barry E., Cassaday, Ryan D., Press, Oliver W., Till, Brian G., Pagel, John M., Palanca-Wessels, Maria C., Philip, Mary, Bensinger, William I., Holmberg, Leona A., Shustov, Andrei R., Green, Damian J., Chauncey, Thomas, Maloney, David G., Libby, Edward N.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4269586/
https://ncbi.nlm.nih.gov/pubmed/24707941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2014.911866
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados